English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
New targeted drugs for metastatic renal cell carcinoma
ECCO 15 - ESMO 34
20 - 24 Sep 2009
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
25 Sep 2009
Views:
12070
Rating:
Save
Rate video
Dr Joaquim Bellmunt - Section Chief, Solid Tumor Oncology, Hospital del Mar, Barcelona, Spain
Expert interview with Dr Joaquim Bellmunt MD PhD conducted by Prof Gordon McVie
Categories:
Hepatobiliary pancreatic
Related Videos
Palliative radiotherapy for symptomatic hepatocellular carcinoma improves...
Prof Laura Dawson - University of Toronto, Toronto, Canada
7 Feb 2023
Stereotactic body radiation therapy (SBRT) followed by sorafenib in HCC...
Prof Laura Dawson - University of Toronto, Toronto, Canada
7 Feb 2023
Intraoperative Radiotherapy
Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal
25 Sep 2022
Adjuvant nivolumab plus ipilimumab vs placebo for localised renal cell...
Dr Robert Motzer, Memorial Sloan Kettering Cancer Center, New York, USA
11 Sep 2022
Tislelizumab OS benefit vs sorafenib as first line treatment for unresectable...
Prof Richard S Finn - UCLA Health Santa Monica Cancer Care, Santa Monica, USA
11 Sep 2022
Lenvatinib remains standard of care for first-line therapy in advanced...
Prof Richard S Finn - UCLA Health Santa Monica Cancer Care, Santa Monica, USA
11 Sep 2022
Perioperative nivolumab did not improve RFS in RCC patients at high risk for...
Dr Mohamad Allaf - The Johns Hopkins Hospital, Baltimore, USA
10 Sep 2022
Physical activity improves quality of life for patients with pancreatic cancer
Dr Mike Cusnir - Mount Sinai Medical Center, Florida, USA
8 Jul 2022
Pancreatic neuroendocrine tumours: Capecitabine plus temozolomide gives longer...
Dr Pamela Kunz - Yale Cancer Center, New Haven, USA
6 Jun 2022
More from
e
cancer